• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Exact Sciences Corporation - Common Stock (NQ:EXAS)

    102.23 +0.12 (+0.12%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Exact Sciences Corporation - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    21 22 Next >
    News headline image
    Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
    On January 12, 2026, the diagnostic sector witnessed a seismic shift as shares of Biodesix (Nasdaq: BDSX) surged more than 40% in early trading, following the release of preliminary full-year 2025... 
    Via MarketMinute
    Topics Artificial Intelligence Death
    News headline image
    Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights
    Shareholders should contact the firm as there may be limited time to enforce your rights. 
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    3 Mid-Cap Stocks We Steer Clear Of
    Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
    Via StockStory
    Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗
    Via Stocktwits
    Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗
    Via Stocktwits
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    1 High-Flying Stock on Our Watchlist and 2 We Question
    "You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
    Via StockStory
    News headline image
    3 Unpopular Stocks We Steer Clear Of
    Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
    Via StockStory
    News headline image
    Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
    From Exact Sciences Corp.
    Via Business Wire
    News headline image
    1 Healthcare Stock for Long-Term Investors and 2 We Avoid
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have realized strong financial performance, and over the past six months, the... 
    Via StockStory
    Topics Stocks
    News headline image
    3 Overrated Stocks That Concern Us
    The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro... 
    Via StockStory
    News headline image
    Here's Why Grail Soared, Again, in November ↗
    A combination of operational improvements and developments at its key rival bolstered the stock recently. 
    Via The Motley Fool
    News headline image
    This Top Dividend King Just Became an Even Better Buy ↗
    The healthcare leader wants to make waves in a potentially highly lucrative market. 
    Via The Motley Fool
    News headline image
    Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
    Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium
    From Exact Sciences Corp.
    Via Business Wire
    News headline image
    Unusual volume stocks are being observed in Monday's session. ↗
    Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
    Via Chartmill
    News headline image
    Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks
    As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers. 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights
    Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗
    On a big day for tech stocks, some other less well-known companies saw even larger moves. 
    Via The Motley Fool
    Topics Artificial Intelligence Stocks
    News headline image
    Why Exact Sciences Rallied Over 50% This Week ↗
    The company received a buyout offer from Abbot Labs. 
    Via The Motley Fool
    News headline image
    SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Why Exact Sciences Stock Surged Today ↗
    A healthcare giant covets the cancer screening leader's technology. 
    Via The Motley Fool
    News headline image
    Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗
    Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday. 
    Via Benzinga
    News headline image
    Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗
    Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum. 
    Via Benzinga
    News headline image
    EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Abbott To Acquire Exact Sciences For Up To $23B ↗
    Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. 
    Via Stocktwits
    News headline image
    Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗
    A strategic investor is reportedly in advanced talks to purchase the company. 
    Via The Motley Fool
    News headline image
    2 Surging Stocks with Competitive Advantages and 1 We Question
    The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
    Via StockStory
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    21 22 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.